# Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency

> **NCT02789397** · PHASE2 · WITHDRAWN · sponsor: **Medical College of Wisconsin**

## Conditions studied

- Granulomatous and Lymphocytic Interstitial Lung Disease

## Interventions

- **DRUG:** Rituximab (RTX) and Azathioprine (AZA)
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02789397
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05-02
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding for study.
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789397, "Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02789397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*